AL-1095
AL-1095,[1] developed by Aldrich, is a centrally acting stimulant drug with comparable effects to amphetamine,[2] developed by Bristol in the 1970s.[3]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C20H22ClNO |
Molar mass | 327.139 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
|
References
- US Patent 3506673 -2-(4'HALO)-BENZHYDRYL-3-QUINUCLIDINOLS
- Hedblom, P.; Grinspoon, L. (1975). The Speed Culture: Amphetamine Use and Abuse in America. Cambridge: Harvard University Press. p. 50. ISBN 0-674-83192-6.
- Warawa, E. J.; Mueller, N. J.; Gylys, J. A. (1975). "Quinuclidine Chemistry. 3. β-cis-2-(4'-Chlorobenzhydryl)-3-quinuclidinol, a New Central Nervous System Stimulant. Importance of the Benzhydryl Configuration". Journal of Medicinal Chemistry. 18 (1): 71–74. doi:10.1021/jm00235a016. PMID 803245.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.